| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
David Robert Mole
|
||||||||
| GSM8328455 |
RCC4 control siRNA rep1
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328456 |
RCC4 control siRNA rep2
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328457 |
RCC4 control siRNA rep3
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328458 |
RCC4 HIF1A siRNA rep1
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328459 |
RCC4 HIF1A siRNA rep2
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328460 |
RCC4 HIF1A siRNA rep3
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328461 |
RCC4 HIF2A siRNA rep1
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328462 |
RCC4 HIF2A siRNA rep2
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328463 |
RCC4 HIF2A siRNA rep3
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328464 |
RCC4 HIF1A siRNA and HIF2A siRNA rep1
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328465 |
RCC4 HIF1A siRNA and HIF2A siRNA rep2
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328466 |
RCC4 HIF1A siRNA and HIF2A siRNA rep3
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328549 |
N17 normoxia
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328550 |
N17 physoxia
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328551 |
N17 hypoxia
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328552 |
T17A
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328553 |
T17B
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328554 |
T17C
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328555 |
T17D
|
SRA | 1 | David Robert Mole | Dec 18, 2024 | ||||
| GSM8328556 |
T17E
|
SRA | 1 | David Robert Mole | Dec 18, 2024 |
